These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10101744)

  • 21. Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma.
    Krishna MT; Chauhan A; Little L; Sampson K; Hawksworth R; Mant T; Djukanovic R; Lee T; Holgate S
    J Allergy Clin Immunol; 2001 Jun; 107(6):1039-45. PubMed ID: 11398082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep.
    Abraham WM; Ahmed A; Sabater JR; Lauredo IT; Botvinnikova Y; Bjercke RJ; Hu X; Revelle BM; Kogan TP; Scott IL; Dixon RA; Yeh ET; Beck PJ
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1205-14. PubMed ID: 10194167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.
    Israel E; Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Shapiro J; Cohn J; Rubin P; Drazen JM
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1447-51. PubMed ID: 8256883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of a cysteinyl leukotriene antagonist (ONO-1078) on antigen-induced responses in allergic sheep.
    Abraham WM; Ahmed A; Cortes A; Sielczak M; Hallmon J
    Prostaglandins Leukot Essent Fatty Acids; 1993 Mar; 48(3):233-9. PubMed ID: 8469683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study of zileuton, a novel selective 5-lipoxygenase inhibitor, in patients with systemic lupus erythematosus.
    Hackshaw KV; Shi Y; Brandwein SR; Jones K; Westcott JY
    J Rheumatol; 1995 Mar; 22(3):462-8. PubMed ID: 7783062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A bradykinin antagonist modifies allergen-induced mediator release and late bronchial responses in sheep.
    Abraham WM; Burch RM; Farmer SG; Sielczak MW; Ahmed A; Cortes A
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):787-96. PubMed ID: 2008991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease.
    Berger W; De Chandt MT; Cairns CB
    Int J Clin Pract; 2007 Apr; 61(4):663-76. PubMed ID: 17394438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of late-phase airway responses and airway hyperresponsiveness in allergic sheep with a small-molecule peptide inhibitor of VLA-4.
    Abraham WM; Ahmed A; Sielczak MW; Narita M; Arrhenius T; Elices MJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):696-703. PubMed ID: 9309981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep.
    Clark JM; Abraham WM; Fishman CE; Forteza R; Ahmed A; Cortes A; Warne RL; Moore WR; Tanaka RD
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2076-83. PubMed ID: 8520778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxynitrite-induced nitrotyrosination of proteins is blocked by direct 5-lipoxygenase inhibitor zileuton.
    Coffey MJ; Phare SM; Peters-Golden M
    J Pharmacol Exp Ther; 2001 Oct; 299(1):198-203. PubMed ID: 11561080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of inhaled thiorphan on allergen-induced airway responses in asthmatic subjects.
    Diamant Z; Van der Veen H; Kuijpers EA; Bakker PF; Sterk PJ
    Clin Exp Allergy; 1996 May; 26(5):525-32. PubMed ID: 8735864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of alpha 1-proteinase inhibitor and tissue kallikrein in controlling allergic ovine airway hyperresponsiveness.
    Forteza R; Botvinnikova Y; Ahmed A; Cortes A; Gundel RH; Wanner A; Abraham WM
    Am J Respir Crit Care Med; 1996 Jul; 154(1):36-42. PubMed ID: 8680696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theophylline inhibits the late asthmatic response to nighttime antigen challenge in patients with mild atopic asthma.
    Jarjour NN; Lacouture PG; Busse WW
    Ann Allergy Asthma Immunol; 1998 Sep; 81(3):231-6. PubMed ID: 9759799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of nonanesthetized guinea pigs.
    Hutson PA; Holgate ST; Church MK
    Am Rev Respir Dis; 1988 Nov; 138(5):1157-63. PubMed ID: 3144212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separation of late bronchial responses from airway hyperresponsiveness in allergic sheep.
    Solér M; Sielczak M; Abraham WM
    J Appl Physiol (1985); 1991 Feb; 70(2):617-23. PubMed ID: 2022553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization.
    Woodruff PG; Albert RK; Bailey WC; Casaburi R; Connett JE; Cooper JA; Criner GJ; Curtis JL; Dransfield MT; Han MK; Harnden SM; Kim V; Marchetti N; Martinez FJ; McEvoy CE; Niewoehner DE; Reilly JJ; Rice K; Scanlon PD; Scharf SM; Sciurba FC; Washko GR; Lazarus SC;
    COPD; 2011 Feb; 8(1):21-9. PubMed ID: 21299475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABT-761 (Abbott).
    Reid JJ
    Curr Opin Investig Drugs; 2001 Jan; 2(1):68-71. PubMed ID: 11527015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The allergen specificity of the late asthmatic reaction.
    Hatzivlassiou M; Grainge C; Kehagia V; Lau L; Howarth PH
    Allergy; 2010 Mar; 65(3):355-8. PubMed ID: 19804443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors.
    Drazen J
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S233-7; discussion S247-8. PubMed ID: 9647605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
    Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G
    Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.